MXPA02000752A - Alo-anticuerpos cataliticos anti-factor viii. - Google Patents

Alo-anticuerpos cataliticos anti-factor viii.

Info

Publication number
MXPA02000752A
MXPA02000752A MXPA02000752A MXPA02000752A MXPA02000752A MX PA02000752 A MXPA02000752 A MX PA02000752A MX PA02000752 A MXPA02000752 A MX PA02000752A MX PA02000752 A MXPA02000752 A MX PA02000752A MX PA02000752 A MXPA02000752 A MX PA02000752A
Authority
MX
Mexico
Prior art keywords
antibodies
factor viii
catalytic anti
viii allo
allo
Prior art date
Application number
MXPA02000752A
Other languages
English (en)
Inventor
Kaveri Srinivas
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Publication of MXPA02000752A publication Critical patent/MXPA02000752A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MXPA02000752A 1999-07-21 2000-07-18 Alo-anticuerpos cataliticos anti-factor viii. MXPA02000752A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99401841A EP1074842A1 (en) 1999-07-21 1999-07-21 Catalytic anti-factor VIII allo-antibodies
PCT/EP2000/006870 WO2001007918A1 (en) 1999-07-21 2000-07-18 Catalytic anti-factor viii allo-antibodies

Publications (1)

Publication Number Publication Date
MXPA02000752A true MXPA02000752A (es) 2003-07-14

Family

ID=8242069

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02000752A MXPA02000752A (es) 1999-07-21 2000-07-18 Alo-anticuerpos cataliticos anti-factor viii.

Country Status (24)

Country Link
US (2) US7507540B1 (es)
EP (2) EP1074842A1 (es)
JP (2) JP2003505434A (es)
KR (1) KR100788435B1 (es)
CN (1) CN1229646C (es)
AU (1) AU777615B2 (es)
BR (1) BR0012613A (es)
CA (1) CA2379818A1 (es)
CZ (1) CZ2002248A3 (es)
EE (1) EE200200034A (es)
HK (1) HK1044372A1 (es)
HU (1) HUP0201941A3 (es)
IL (1) IL147700A0 (es)
IS (1) IS6238A (es)
MX (1) MXPA02000752A (es)
NO (1) NO20020253L (es)
NZ (1) NZ516702A (es)
PL (1) PL353739A1 (es)
RU (1) RU2258935C2 (es)
SK (1) SK862002A3 (es)
TR (1) TR200200340T2 (es)
UA (1) UA75867C2 (es)
WO (1) WO2001007918A1 (es)
ZA (1) ZA200200351B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI452136B (zh) 2010-11-17 2014-09-11 中外製藥股份有限公司 A multiple specific antigen-binding molecule that replaces the function of Factor VIII in blood coagulation
FR2969761A1 (fr) * 2010-12-22 2012-06-29 Lfb Biotechnologies Procede de dosage d'anticorps diriges contre le facteur viii
TWI700300B (zh) 2014-09-26 2020-08-01 日商中外製藥股份有限公司 中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體
TWI701435B (zh) * 2014-09-26 2020-08-11 日商中外製藥股份有限公司 測定ｆｖｉｉｉ的反應性之方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744446A (en) * 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
AU5602394A (en) * 1992-11-13 1994-06-08 Duke University Chimeric blood coagulation proteins
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
US5744326A (en) * 1996-03-11 1998-04-28 The Immune Response Corporation Use of viral CIS-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sites

Also Published As

Publication number Publication date
IL147700A0 (en) 2002-08-14
UA75867C2 (en) 2006-06-15
EE200200034A (et) 2003-06-16
CZ2002248A3 (cs) 2002-07-17
RU2258935C2 (ru) 2005-08-20
HK1044372A1 (zh) 2002-10-18
US7507540B1 (en) 2009-03-24
KR100788435B1 (ko) 2007-12-24
AU777615B2 (en) 2004-10-21
US20090208512A1 (en) 2009-08-20
NO20020253D0 (no) 2002-01-17
CA2379818A1 (en) 2001-02-01
NO20020253L (no) 2002-03-13
JP2003505434A (ja) 2003-02-12
AU6824500A (en) 2001-02-13
HUP0201941A3 (en) 2005-01-28
KR20020042618A (ko) 2002-06-05
IS6238A (is) 2002-01-16
TR200200340T2 (tr) 2003-01-21
HUP0201941A2 (en) 2002-10-28
JP2009292823A (ja) 2009-12-17
CN1229646C (zh) 2005-11-30
ZA200200351B (en) 2003-03-26
CN1361865A (zh) 2002-07-31
EP1074842A1 (en) 2001-02-07
PL353739A1 (en) 2003-12-01
EP1196782A1 (en) 2002-04-17
BR0012613A (pt) 2002-04-09
SK862002A3 (en) 2002-06-04
NZ516702A (en) 2003-10-31
WO2001007918A1 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
ZA200103880B (en) Catalyst.
ZA200204473B (en) Organometal catalyst compositions.
GC0000068A (en) Catalyst composition.
GC0000261A (en) Organometal catalyst compositions
ZA200109202B (en) Esterification catalysts.
ZA200201269B (en) Toothbrush.
GC0000154A (en) Cobalt catalysts.
MXPA03002290A (es) Composiciones de champu con polimeros cationicos.
ZA200203817B (en) Reduced side-effect hemoglobin compositions.
ZA200203768B (en) Toothbrush.
HUP0202644A3 (en) Organometal catalyst compositions
GB9907154D0 (en) Polymerisation catalysts
HK1054848A1 (en) Toothbrush.
ZA200203177B (en) Regeneration.
MXPA02000752A (es) Alo-anticuerpos cataliticos anti-factor viii.
EG22301A (en) Polymerisation catalysts
GB0029720D0 (en) I.S machine7544232001
GB9911245D0 (en) Polymerisation catalysts
GB9914200D0 (en) Catalysts
MXPA03003389A (es) Sistema catalizador del grupo 3 cationico.
ZA991537B (en) Catalyst composition.
ZA200110532B (en) Carbonylation reactions.
ZA200001571B (en) Switch point.
ZA200204825B (en) Organometal catalyst compositions.
ZA200007594B (en) Catalyst body.